BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 17456528)

  • 41. Quantiferon TB Gold and tuberculin skin tests for the detection of latent tuberculosis infection in patients treated with tumour necrosis factor alpha blocking agents.
    Klein M; Jarosová K; Forejtová S; Bečvář R; Sedová L; Pavelka K; Simková G; Svobodová R; Hviscová K; Mann H; Půtová I; Vencovský J
    Clin Exp Rheumatol; 2013; 31(1):111-7. PubMed ID: 23101473
    [TBL] [Abstract][Full Text] [Related]  

  • 42. ELISPOT-IFN-gamma assay instead of tuberculin skin test for detecting latent Mycobacterium tuberculosis infection in rheumatic patients candidate to anti-TNF-alpha treatment.
    Girlanda S; Mantegani P; Baldissera E; Aiello P; Ratti M; Sabbadini MG; Fortis C
    Clin Rheumatol; 2010 Oct; 29(10):1135-41. PubMed ID: 20645117
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Interferon-γ release assay for tuberculosis in patients with psoriasis treated with tumour necrosis factor antagonists: in vivo and in vitro analysis.
    Sauzullo I; Mengoni F; Marocco R; Potenza C; Skroza N; Tieghi T; Lichtner M; Vullo V; Mastroianni CM
    Br J Dermatol; 2013 Nov; 169(5):1133-40. PubMed ID: 23909256
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [The in-vitro interferon-gamma release assay for the diagnosis of tuberculosis and Mycobacterium tuberculosis infections].
    Xie L; Ma Y; Gao WW; Li CY; Zhang ZD; Chen XY; Gu SX; Xing AY; Zheng SH; Liu ZQ; Chen X; Han XQ
    Zhonghua Jie He He Hu Xi Za Zhi; 2005 Aug; 28(8):545-9. PubMed ID: 16207403
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prospective evaluation of a whole-blood test using Mycobacterium tuberculosis-specific antigens ESAT-6 and CFP-10 for diagnosis of active tuberculosis.
    Ravn P; Munk ME; Andersen AB; Lundgren B; Lundgren JD; Nielsen LN; Kok-Jensen A; Andersen P; Weldingh K
    Clin Diagn Lab Immunol; 2005 Apr; 12(4):491-6. PubMed ID: 15817755
    [TBL] [Abstract][Full Text] [Related]  

  • 46. New tools and emerging technologies for the diagnosis of tuberculosis: part I. Latent tuberculosis.
    Pai M; Kalantri S; Dheda K
    Expert Rev Mol Diagn; 2006 May; 6(3):413-22. PubMed ID: 16706743
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Screening for latent tuberculosis infection in patients with chronic inflammatory arthritis: discrepancies between tuberculin skin test and interferon-γ release assay results.
    Costantino F; de Carvalho Bittencourt M; Rat AC; Loeuille D; Dintinger H; Béné MC; Faure G; Chary-Valckenaere I
    J Rheumatol; 2013 Dec; 40(12):1986-93. PubMed ID: 24085550
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Interferon-γ release assays for diagnosis of tuberculosis infection and disease in children.
    Starke JR;
    Pediatrics; 2014 Dec; 134(6):e1763-73. PubMed ID: 25422024
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical evaluation for diagnosing active TB disease and transitional change of two commercial blood tests.
    Kobashi Y; Mouri K; Yagi S; Obase Y; Miyashita N; Okimoto N; Matsushima T; Kageoka T; Oka M
    Scand J Infect Dis; 2008; 40(8):629-34. PubMed ID: 18642159
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Comparison of interferon-gamma whole blood assay with tuberculin skin test for the diagnosis of tuberculosis infection in tuberculosis contacts].
    Oztürk N; Sürücüoğlu S; Ozkütük N; Gazi H; Akçali S; Köroğlu G; Ciçek C
    Mikrobiyol Bul; 2007 Apr; 41(2):193-202. PubMed ID: 17682705
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Is the T-cell-based interferon-gamma releasing assay feasible for diagnosis of latent tuberculosis infection in an intermediate tuberculosis-burden country?
    Dilektasli AG; Erdem E; Durukan E; Eyüboğlu FÖ
    Jpn J Infect Dis; 2010 Nov; 63(6):433-6. PubMed ID: 21099095
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effectiveness of the combination of a whole-blood interferon-gamma assay and the tuberculin skin test in detecting latent tuberculosis infection in rheumatoid arthritis patients receiving adalimumab therapy.
    Chen DY; Shen GH; Hsieh TY; Hsieh CW; Lan JL
    Arthritis Rheum; 2008 Jun; 59(6):800-6. PubMed ID: 18512714
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Performance of whole blood IFN-gamma test for tuberculosis diagnosis based on PPD or the specific antigens ESAT-6 and CFP-10.
    Brock I; Munk ME; Kok-Jensen A; Andersen P
    Int J Tuberc Lung Dis; 2001 May; 5(5):462-7. PubMed ID: 11336278
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluation of QuantiFERON-TB Gold In-Tube in human immunodeficiency virus infection and in patient candidates for anti-tumour necrosis factor-alpha treatment.
    Sauzullo I; Mengoni F; Scrivo R; Valesini G; Potenza C; Skroza N; Marocco R; Lichtner M; Vullo V; Mastroianni CM
    Int J Tuberc Lung Dis; 2010 Jul; 14(7):834-40. PubMed ID: 20550765
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Diagnosis of tuberculosis infection by tuberculin skin test and a whole-blood interferon-γ release assay in patients considered for anti-tumor necrosis factor-α therapy.
    Casas S; Andreu A; Juanola X; Bordas X; Alcaide F; Moure R; Anibarro L; Cuchí E; Esteve M; Ortiz V; Guerra MR; Rodríguez J; Reina D; Salvador G; Guardiola J; Surís X; Pascual MA; Martí C; Martínez-Lacasa X; Cuquet J; Gonzalez L; Santin M
    Diagn Microbiol Infect Dis; 2011 Sep; 71(1):57-65. PubMed ID: 21851871
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of tuberculin skin testing and QuantiFERON-TB Gold-In Tube test in health care workers.
    Cağlayan V; Ak O; Dabak G; Damadoğlu E; Ketenci B; Ozdemir M; Ozer S; Saygı A
    Tuberk Toraks; 2011; 59(1):43-7. PubMed ID: 21554229
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of gamma interferon release assays using Mycobacterium tuberculosis antigens for diagnosis of latent and active tuberculosis in Mycobacterium bovis BCG-vaccinated populations.
    Zhang S; Shao L; Mo L; Chen J; Wang F; Meng C; Zhong M; Qiu L; Wu M; Weng X; Zhang W
    Clin Vaccine Immunol; 2010 Dec; 17(12):1985-90. PubMed ID: 20943878
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Interferon-inducible protein-10 as a marker to detect latent and active tuberculosis in rheumatoid arthritis.
    Chen DY; Shen GH; Chen YM; Chen HH; Lin CC; Hsieh CW; Lan JL
    Int J Tuberc Lung Dis; 2011 Feb; 15(2):192-200. PubMed ID: 21219680
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Screening for tuberculosis infection prior to initiation of anti-TNF therapy.
    Lalvani A; Millington KA
    Autoimmun Rev; 2008 Dec; 8(2):147-52. PubMed ID: 18706526
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Interferon-gamma assays for the diagnosis of tuberculosis infection before using tumour necrosis factor-alpha blockers.
    Cobanoglu N; Ozcelik U; Kalyoncu U; Ozen S; Kiraz S; Gurcan N; Kaplan M; Dogru D; Yalcin E; Pekcan S; Kose M; Topaloglu R; Besbas N; Bakkaloglu A; Kiper N
    Int J Tuberc Lung Dis; 2007 Nov; 11(11):1177-82. PubMed ID: 17958978
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.